The design and enzymatic hydrolysis of activatable cell-penetrating peptide

Yaoxue Xuebao

Volumn 45, Issue 8, 2010, Pages 1048-1051

  Wang, Peng Cheng ^a   Qi, Xian Rong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cell penetrating peptide; Enzymatic hydrolysis; Matrix assisted laser desorption ionization orthogonal time of flight mass spectrometry; Matrix metalloproteinase; Reversed phase high performance liquid chromatography

Indexed keywords

ACTIVATABLE CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE; GELATINASE A; GELATINASE B; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; HYDROLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; CELL-PENETRATING PEPTIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROLYSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PEPTIDE FRAGMENTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77957911912     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Goncüalves E, Kitas E, Seelig J. Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide [J]. Biochemistry, 2005, 44: 2692-2702. (Pubitemid 40279574)
2. Zorko M, Langel Ü. Cell-penetrating peptides: mechanism and kinetics of cargo delivery [J]. Adv Drug Deliv Rev, 2005, 57: 529-545. (Pubitemid 40255559)
3. Järver P, Langel Ü. Cell-penetrating peptides - a brief introduction [J]. Biochim Biophys Acta, 2006, 1758: 260-263.
4. Ren J, Qin CG, Xu CL, et al. Development of cell-penetrating peptides as vectors for drug delivery [J]. Acta Pharm Sin, 2010, 45: 17-25.
5. Jiang T, Olson ES, Nguyen QT, et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides [J]. PNAS, 2004, 101: 17867-17872. (Pubitemid 40051978)
6. Van der Jagt M, Sweep F, Waas E, et al. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer [J]. Cancer Lett, 2006, 237: 289-297.
7. Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers [J]. Biochimie, 2005, 87: 287-297. (Pubitemid 40387607)
8. Netzel-Arnett S, Sang QX, Moore WG, et al. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin) [J]. Biochemistry 1993, 32: 6427-6432. (Pubitemid 23208826)
9. Seltzer JL, Akers KT, Weingarten H, et al. Cleavage specificity of human skin type IV collagenase (gelatinase) [J]. J Biol Chem, 1990, 265: 20409-20413.
10. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases [J]. FEBS, 1992, 296: 263-266.
11. Lee GY, Park K, Kim SY, et al. MMPs-specific PEGylated peptide - DOX conjugate micelles that can contain free doxorubicin [J]. Eur J Pharm Biopharm, 2007, 67: 646-654.
12. Sun ZY, Wu S, Wang SQ, et al. Application of liquid chromatography- electrospray ionization mass spectrometry in protein sequencing [J]. Basic Med Sci Clin, 2003, 23: 126-130.
13. Wang XC, Fan CM, Tang XK, et al. Chromatography/nass spectrometric analysis of BSA digest and comparison of protein identification through database search with three different methods [J]. Chin J Biochem Mol Biol, 2004, 20: 393-398.